Skip to content

Prevalence of anal HPV infection and HPV-related precancerous lesions among MSM population in China

Prevalence of anal HPV infection and HPV-related precancerous lesions among MSM population in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085602
Enrollment
Unknown
Registered
2024-06-13
Start date
2024-06-20
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal HPV infection and associated precancerous lesions

Interventions

Observation group:NA

Sponsors

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Participants =18 years old. (2) Participants must identify as men who have sex with men, have had active or passive anal sex with other men in the past 365 days. (3) Participants who provide written informed consent.

Exclusion criteria

Exclusion criteria: (1) Treatment for anal intraepithelial neoplasia (AIN) or other anal lesions in the past 6 months. (2) Having other serious illnesses. (including malignant tumors, severe cardiovascular and cerebrovascular diseases, advanced chronic diseases, deep coma, permanent paralysis, severe brain damage, severe Parkinson's disease and severe mental illness, etc.) (3) Participating in HPV vaccine clinical trials.

Design outcomes

Primary

MeasureTime frame
The prevalence of any type of HPV in the anus of MSM population;The infection rate of high-risk HPV, 9v-HPV and low-risk HPV in anus of MSM population;Abnormal rate of cytological diagnosis;Abnormal rate of histopathological diagnosis;

Secondary

MeasureTime frame
HIV+ / HIV-MSM population random HPV infection rate;HIV+ / HIV-MSM population high risk HPV, 9v-HPV, low risk HPV infection rate;Abnormal cytological diagnosis rate and histopathological diagnosis rate of HIV+ / HIV-MSM population;

Countries

China

Contacts

Public ContactZhao Fanghui

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

zhaofangh@cicams.ac.cn+86 10 8778 8977

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026